Säemann, Marcus D.

The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response

Weichhart, T., Costantino, G., Poglitsch, M., Rosner, M., Zeyda, M., Stuhlmeier, K. M., Kolbe, T., Stulnig, T. M., Hörl, W. H., Hengstschläger, M., et al. (2008) · Immunity

Immune Response and InflammationPI3K/AKT/mTOR signaling in cancer

Cited by 801

Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions

Sharif, A., Hecking, M., de Vries, A. P. J., Porrini, E., Hornum, M., Rasoul-Rockenschaub, S., Berlakovich, G., Krebs, M., Kautzky-Willer, A., Schernthaner, G., et al. (2014) · American Journal of Transplantation

Renal Transplantation Outcomes and TreatmentsDiabetes Management and Research

Cited by 532

Serum Amyloid A in Uremic HDL Promotes Inflammation

Weichhart, T., Kopecky, C., Kubicek, M., Haidinger, M., Döller, D., Katholnig, K., Suarna, C., Eller, P., Tölle, M., Gerner, C., et al. (2012) · Journal of the American Society of Nephrology

Dialysis and Renal Disease ManagementCholesterol and Lipid Metabolism

Cited by 201

Neutralization of Osteopontin Inhibits Obesity-Induced Inflammation and Insulin Resistance

Kiefer, F. W., Zeyda, M., Gollinger, K., Pfau, B., Neuhofer, A., Weichhart, T., Säemann, M. D., Geyeregger, R., Schlederer, M., Kenner, L., et al. (2010) · Diabetes

Adipokines, Inflammation, and Metabolic DiseasesBone and Dental Protein Studies

Cited by 200

Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells

Weichhart, T., Haidinger, M., Katholnig, K., Kopecky, C., Poglitsch, M., Lassnig, C., Rosner, M., Zlabinger, G. J., Hengstschläger, M., Müller, M., et al. (2011) · Blood

PI3K/AKT/mTOR signaling in cancerImmune Response and Inflammation

Cited by 141

Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety

Schwaiger, E., Burghart, L., Signorini, L., Ristl, R., Kopecky, C., Tura, A., Pacini, G., Wrba, T., Antlanger, M., Schmaldienst, S., et al. (2019) · American Journal of Transplantation

Diabetes Treatment and ManagementRenal Transplantation Outcomes and Treatments

Cited by 133

Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation–a randomized, double-blind, placebo-controlled trial

Haidinger, M., Werzowa, J., Hecking, M., Antlanger, M., Stemer, G., Pleiner, J., Kopecky, C., Kovarik, J. J., Döller, D., Pacini, G., et al. (2014) · American Journal of Transplantation

Diabetes Treatment and ManagementRenal Transplantation Outcomes and Treatments

Cited by 110

Vildagliptin and Pioglitazone in Patients With Impaired Glucose Tolerance After Kidney Transplantation: A Randomized, Placebo-Controlled Clinical Trial

Werzowa, J., Hecking, M., Haidinger, M., Lechner, F., Döller, D., Pacini, G., Stemer, G., Pleiner, J., Frantal, S., & Säemann, M. D. (2013) · Transplantation

Diabetes Treatment and ManagementRenal Transplantation Outcomes and Treatments

Cited by 87